Clinical Trials Logo

wetAMD clinical trials

View clinical trials related to wetAMD.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02103738 Completed - wetAMD Clinical Trials

Canadian Treat and Extend Analysis Trial With Ranibizumab

CAN-TREAT
Start date: May 8, 2013
Phase:
Study type: Observational

This is an observational study to will evaluate and compare two Ranibizumab treatment regimens (Standard of care) in patients with neovascular (wet) age-related macular degeneration (wAMD) aiming to achieve and to maintain a maximum visual function benefit. The results will be used to generate further recommendations on the timing of treatment administration for patients with neovascular (wet) age-related macular degeneration (wAMD). In this context, the study will use the anatomical imaging (for example, optical coherence tomography [OCT]) to evaluate wAMD disease activity impacted by the recurrence of disease instability and for decision making in the treatment decision algorithm.